FDA Approved: MYRBETRIQ — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approves MYRBETRIQ (mirabegron) from Astellas Pharma US as the original NDA approval for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

ORIG AP for MYRBETRIQ (MIRABEGRON)